First patient dosed in monalizumab Phase 3 clinical trial triggers $50M payment from AstraZeneca
October 23, 2020 01:00 ET
|
INNATE PHARMA
Milestone payment further bolsters Innate’s cash position INTERLINK-1 represents first Phase 3 study examining IO approach in R/M SCCHN patients who have been treated with a platinum-based therapy...
RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca
October 08, 2020 10:30 ET
|
RedHill Biopharma Ltd.
RedHill obtains Israel rights to Movantik® from AstraZeneca, giving RedHill global rights, excluding Europe and Canada--Movantik approved for opioid-induced constipation in Israel under the brand name...
Agility Key to Post-Pandemic Recovery, ISG Experts Say
September 30, 2020 08:58 ET
|
Information Services Group, Inc.
STAMFORD, Conn., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Leading business thinkers will explore the potential of the agile enterprise and digital operating models to drive success in a post-pandemic...
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
September 01, 2020 07:00 ET
|
Oxford BioMedica plc
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of...
Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate
May 28, 2020 07:38 ET
|
Oxford BioMedica plc
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of...
BrightInsight Announces Global Digital Health Partnership with AstraZeneca
March 25, 2020 08:00 ET
|
BrightInsight
SAN JOSE, Calif., March 25, 2020 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading regulated Internet of Things (IoT) platform for biopharma and medtech, announced today a global...
New global survey shows misperceptions about lung cancer among the general public
November 27, 2019 02:00 ET
|
Lung Ambition Alliance
LONDON, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices...
Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees
October 17, 2019 10:00 ET
|
The Sabin Vaccine Institute
Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its...
INNATE PHARMA PRÉSENTE DES RESULTATS CLINIQUES PRELIMINAIRES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019
October 01, 2019 01:00 ET
|
INNATE PHARMA
Profil de sécurité gérable de la combinaison d’IPH5401 avec durvalumab dans l’étude en escalade de dose STELLAR-001 dans des tumeurs solides avancées Deux extensions de cohorte ont démarré : dans...
Innate Pharma presents early clinical data on IPH5401 and monalizumab at the ESMO 2019 congress
October 01, 2019 01:00 ET
|
INNATE PHARMA
IPH5401 dose-escalation study in combination with durvalumab in advanced solid tumors, STELLAR-001, shows manageable safety profile Initiation of two expansion cohorts in non-small cell lung cancer...